BMIP, launched by government, will function complimentary to international insurers as its global recognition requires time ...
Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results